ERBB2 and breast carcinoma: Her2+ breast cancer cells are characterized by increased protein synthesis load due to chromosomal amplifications and hyperactive Her2/mTOR signaling, which creates dependence on the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway to maintain protein homeostasis and prevent proteotoxic stress [12].